Vaccination & Autism

[K Clifford]

 

Primates Given Vaccines Develop Symptoms of Autism
Click to view press release

Please note: This study was presented at a scientific meeting.  All authors and organizations associated with this study are withholding comment until publication. All quotes in this release have been taken from the study abstracts presented at IMFAR.

National Autism Association Statement

A new landmark study from Dr. Laura Hewittson of the University of Pittsburgh School of Medicine further substantiates a vaccine link to the autism epidemic. Dr. Hewitson reported at IMFAR that monkeys given the same vaccine schedule of US children developed symptoms of autism. “Dr. Hewitson and a respected team of scientists have filled in a missing piece of the vaccine injury – autism puzzle,” Scott Bono, Chairman of the Board of the National Autism Association (NAA) stated when discussing the findings. “This study is exactly the type of study that families of vaccine injured individuals living with autism have long requested – a primate study that actually evaluates the shot schedule linked to the autism epidemic.”

Laura C. Hewitson, PhD presented findings at the prestigious International Meeting for Autism Research (IMFAR) in London that included ‘measurable evidence of developmental delays, behavior problems and brain changes that mimic certain neurological abnormalities of autism in the vaccinated monkeys.’ Conducting the study on macaque monkey infants, scientists found evidence of both behavioral and biological changes after the exposed monkeys were administered proportional doses, adjusted for age, of the vaccines recommended between 1994 and 1999. Using standardized tests the team looked at primate development, cognition and social behavior.  They also conducted MRI and PET scans to look for brain changes.

Collaborating on this research study is a member of NAA's Scientific Advisory Board, Dr. Andrew Wakefield. “Dr. Wakefield has come under attack because he dared evaluate and treat the biomedical needs of autistic children and then report his findings to his peers.  He remains a hero in our community and should be knighted not attacked by the British government,” Mr. Bono concluded.

[David S]

Primates Given Vaccines Develop Symptoms of Autism
Click to view press release

Please note: This study was presented at a scientific meeting.  All authors and organizations associated with this study are withholding comment until publication. All quotes in this release have been taken from the study abstracts presented at IMFAR.

National Autism Association Statement

A new landmark study from Dr. Laura Hewittson of the University of Pittsburgh School of Medicine further substantiates a vaccine link to the autism epidemic. Dr. Hewitson reported at IMFAR that monkeys given the same vaccine schedule of US children developed symptoms of autism. “Dr. Hewitson and a respected team of scientists have filled in a missing piece of the vaccine injury – autism puzzle,” Scott Bono, Chairman of the Board of the National Autism Association (NAA) stated when discussing the findings. “This study is exactly the type of study that families of vaccine injured individuals living with autism have long requested – a primate study that actually evaluates the shot schedule linked to the autism epidemic.”

Laura C. Hewitson, PhD presented findings at the prestigious International Meeting for Autism Research (IMFAR) in London that included ‘measurable evidence of developmental delays, behavior problems and brain changes that mimic certain neurological abnormalities of autism in the vaccinated monkeys.’ Conducting the study on macaque monkey infants, scientists found evidence of both behavioral and biological changes after the exposed monkeys were administered proportional doses, adjusted for age, of the vaccines recommended between 1994 and 1999. Using standardized tests the team looked at primate development, cognition and social behavior.  They also conducted MRI and PET scans to look for brain changes.

Collaborating on this research study is a member of NAA's Scientific Advisory Board, Dr. Andrew Wakefield. “Dr. Wakefield has come under attack because he dared evaluate and treat the biomedical needs of autistic children and then report his findings to his peers.  He remains a hero in our community and should be knighted not attacked by the British government,” Mr. Bono concluded.

Mindblowing stuff...do you have the link to the study, or can you direct me to it?

[Usteo]

Are we comparing apples to apples here? What vaccine was that article discussing?  I'm not interested in this debate, but I stumbled across this and thought I would toss it in for those who are.

California Data Do Not Support a Link Between Thimerosal in Vaccines and Autism

Posted 08/07/2008

William T. Basco, Jr., MD, FAAP
Author Information
Information from Industry
Advanced treatment of ADHD
Learn more about a once-daily treatment that provides day-long symptom control.
Watch a video animation
Continuing Increases in Autism Reported to California's Developmental Services System: Mercury in Retrograde

Schechter R, Grether JK
Arch Gen Psychiatry. 2008;65:19-24
Summary

This study was a retrospective review of autism spectrum disorder (ASD) cases referred to the California Department of Developmental Services (DDS) from 1995 through 2007. Children enter the DDS system at 3 years old; therefore, this referral represents the prevalence of a diagnosis of ASD in this population at the age of 3 years.

The authors plotted the prevalence of ASD referrals against critical time points in US vaccine history relative to the use of thimerosal. Critical dates relative to thimerosal are:

    * 1991: The addition of vaccines to the recommended schedule produces an increase in the total mercury exposure (via thimerosal) in vaccines;

    * 1999: A recommendation to remove thimerosal from vaccines was made;

    * 2001: Thimerosal is no longer present in vaccines except in trace quantities;

    * 2002: The overall expiration time period of vaccines with anything more than trace amounts of thimerosal is reached.

The authors' hypothesis was that if thimerosal were a contributor to ASD then children born and vaccinated after 2002 should have decreased rates of ASD diagnosis, and this would be reflected in decreased numbers of referrals (ie, decreased prevalence) to California DDS.

The authors did not find a dip in referral rates; their data did not reflect a change in ASD prevalence. In fact, the prevalence of ASD was increasing before 1991 and continued on roughly the same slope throughout the 1990s and 2000s, regardless of age group evaluated.

Only one year's cohort of children was born after thimerosal was largely eliminated from vaccines and were not at risk for receiving old vaccine -- the children born in 2003. These children also had a higher prevalence of ASD than children born in previous years, and the slope was increasing along a very similar trajectory to prior years. The increase over the time period 1993 through 2003 was from 0.3 cases per 1000 births to 1.3 cases per 1000 births.

The authors conclude that the California DDS data do not support a link between thimerosal in childhood vaccines and development of ASD.
Viewpoint

This study was published in January 2008 but only recently came to my attention. The findings here mirror those of a Danish study that demonstrated ongoing increases in ASD diagnosis despite removal of thimerosal from vaccines,[1] as well as Canadian data demonstrating no decrease in ASD diagnosis for children vaccinated with non-thimerosal-containing vaccines.[2] The figure from the Canadian study is particularly interesting and is worth viewing separately.

Abstract

[David S]

So why do u think their is an escalating rate of ASD. Note also,that ASD was almost absent in China until kids were exposed to various immunisations.